This invention provides a combination of ATP-competitive BCR-ABL inhibitor and a non-ATP competitive BCR-ABL inhibitor. The combination of the present invention may be used for treating cancers known to be associated with BCR-ABL.
这项发明提供了一种
ATP竞争性BCR-ABL
抑制剂和一种非
ATP竞争性BCR-ABL
抑制剂的组合。本发明的组合可用于治疗已知与BCR-ABL相关的癌症。